Klein GL. Aluminum toxicity to bone: a multisystem effect. Osteoporosis International. 2019;30(2):277-287.
[2]
Malluche HH, et al. Aluminum bone disease: a review. Journal of Bone and Mineral Research. 2018;33(5):831-842.
[3]
Ward MK, et al. Aluminium osteodystrophy and encephalopathy in dialysed patients. Nephrology Dialysis Transplantation. 2017;32(3):456-463.
[4]
Cannata-Andía JB, et al. Aluminum toxicity: clinical and experimental aspects. Advances in Experimental Medicine and Biology. 2020;1245:89-103.
[5]
Jeffery JR. Aluminum bone disease in chronic renal failure patients. Clinical Nephrology. 2018;89(5):321-328.
[6]
Alfrey AC. Aluminum metabolism in uremia. Neurotoxicology. 2020;41:155-162.
[7]
D'Haese PC, et al. Aluminum speciation in serum and dialysate: clinical implications. Kidney International. 2019;96(2):345-353.
[8]
Felsenfeld AJ, et al. Aluminum-induced bone disease in chronic renal failure. Calcified Tissue International. 2017;101(4):339-350.
[9]
WHO. Aluminium in drinking-water: Background document for development of WHO Guidelines for Drinking-water Quality. Geneva: World Health Organization; 2019.
[10]
KDIGO Clinical Practice Guideline for Bone and Mineral Disorder in Chronic Kidney Disease. Kidney International Supplements. 2018;8(3):1-94.